Loading…
Australian private health insurer also offering travel, life and international student health cover.
Australian private health insurer also offering travel, life and international student health cover.
Collects monthly premiums and pays out claims, so profit depends on keeping claims growth below the premium increases the government approves each year. An industry-wide risk equalisation scheme shares the cost of older members' claims across insurers. The Australian resident business carries earnings, with international student and traveller cover as growth lines.
In one line: A mid-size health insurer analogue, but community-rated complementary cover.
Moat: narrow (regulatory licence, scale, brand). APRA health-insurer licence and risk-equalisation scale create barriers, though the market is community-rated and competitive.
Headquarters: Newcastle, Australia · Founded: 1952
Size NIB (NHF.AX) is an Australia Financials company (Multi-Line Insurance) with a market value of $2.29B, the 113th largest of 316 Australia companies the cockpit tracks. Shares closed at A$6.76 on 6 Nov 2026.
Performance Over six months the shares gained 3.5%, against +5.3% for the median peer and +4.1% for the Australia market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 5.3% over the last twelve months (peer median +12.7%); the operating margin is 7.1% (peer median 11.1%).
Valuation It trades at 2.90× book value against a peer median of 1.32× (5th most expensive of 21).
Price implies The share price implies a return on equity of about 13.2%; NIB delivers 16.6%, so the price asks less than the business earns today.
Next results Next results expected around 22 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | A$3.81B | A$3.82B | A$3.56B | A$3.32B | A$3.14B |
| Revenue growth | — | +7% | +7% | +6% | — |
| Net income | A$188M | A$188M | A$200M | A$186M | A$114M |
| Free cash flow | A$165M | A$165M | A$112M | A$217M | A$239M |
| Capital expenditure | A$34.4M | A$34.4M | A$53.6M | A$48.6M | A$52.3M |
| Total debt | n/a | A$230M | A$310M | A$307M | A$292M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE |
|---|---|---|---|---|---|---|
| NIB NHF.AX | $2.29B | +4% | +5% | 17% | 2.90× | 13.2% |
| Medibank Private MPL.AX | $9.94B | +14% | +9% | 27% | 5.90× | 23.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | NHF.AX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.0% | +2.3% | 7th highest of 21 |
| 6-month return | +3.5% | +5.3% | 11th highest of 21 |
| Return on equity | 16.6% | 9.0% | 7th highest of 21 |
| Price / book | 2.90× | 1.32× | 5th most expensive of 21 |
| Trailing P/E | 17.6× | 13.3× | 6th most expensive of 19 |
| ROE the price implies | 13.2% | 8.4% | 7th most demanding of 20 |
| ROE delivered | 16.6% | 8.8% | 7th highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| NIB NHF.AX | Australia | $2.29B | +4% | +5% | 17% | 2.90× | 13.2% | 16.6% |
| Pelagos Insurance Capital PLGO | United States | $2.29B | +33% | -4% | 18% | 1.03× | 6.5% | 17.6% |
| Seoul Guarantee Insurance 031210.KS | South Korea | $2.26B | -8% | +14% | 6% | 0.61× | 4.5% | 6.0% |
| Go Digit General Insurance GODIGIT.NS | India | $2.44B | -21% | +9% | 12% | 4.91× | 37.4% | n/a |
| Zhongan Online P&C Insurance 6060.HK | Hong Kong | $2.06B | -19% | +16% | 8% | 0.54× | 8.0% | 8.2% |
| Vaudoise Assurances VAHN.SW | Switzerland | $2.66B | -8% | +14% | 6% | 0.78× | n/a | 5.9% |
| Skyward Specialty Insurance SKWD | United States | $2.68B | +29% | +38% | 17% | 2.11× | 10.2% | 17.3% |
| New India Assurance NIACL.NS | India | $2.74B | -5% | +9% | -1% | 0.62× | 14.0% | -1.3% |
| Korean Reinsurance 003690.KS | South Korea | $1.74B | +8% | -2% | 14% | 0.73× | 4.8% | 14.4% |
| Lemonade LMND | United States | $3.06B | -28% | +77% | -27% | 6.12× | 75.0% | -27.0% |
| F&G Annuities & Life FG | United States | $3.06B | -17% | +14% | 9% | 0.66× | 8.4% | 9.2% |
| Trupanion TRUP | United States | $1.61B | +49% | +12% | 6% | 3.94× | 35.3% | 6.1% |
| Genworth Financial GNW | United States | $3.29B | -5% | -1% | 2% | 0.38× | 5.3% | 2.3% |
| Linea Directa Aseguradora LDA.MC | Spain | $1.48B | +3% | +10% | 23% | 3.07× | 11.7% | 23.3% |
| Hamilton Insurance HG | United States | $3.64B | +20% | +20% | 19% | 1.24× | 8.0% | 19.0% |
| Alm. Brand A/S ALMB.CO | Denmark | $3.70B | +16% | +3% | 9% | 2.19× | 7.3% | 8.8% |
| Wuestenrot & Wuerttembergische WUW.DE | Germany | $1.39B | -6% | +4% | 3% | 0.25× | 3.6% | 2.7% |
| Central Reinsurance 2851.TW | Taiwan | $1.12B | +52% | +21% | 37% | 1.41× | 5.1% | 37.4% |
| Bowhead Specialty BOW | United States | $1.12B | +26% | +24% | 14% | 2.48× | 11.3% | 13.6% |
| Chesnara CSN.L | United Kingdom | $1.08B | +11% | +192% | 0% | 2.14× | 15.7% | 0.3% |
| CNO Financial CNO | United States | $5.09B | +20% | +2% | 17% | 2.19× | 16.0% | 16.9% |